Aggies End Cancer

Symposium ‘Cancer Research: Basic science to Bioinformatics’, on Oct 11th, at Texas A&M University, with @TAMU_Biology @TAMUArtSci @AlexCarlKeene @mahulchak @Irtisha_Singh @TAMUstats

BREAKING NEWS The Royal Swedish Academy of Sciences has decided to award the 2024 #NobelPrize in Physics to John J. Hopfield and Geoffrey E. Hinton “for foundational discoveries and inventions that enable machine learning with artificial neural networks.”

Did you know there are different kinds of #BreastCancer? 69% of all breast cancer diagnoses are from the HR+/HER2- subtype. Visit our Cancer Stat Facts sheet to learn more: seer.cancer.gov/statfacts/html…

A human tumor microenvironment chip for ovarian cancer science.org/doi/10.1126/sc… @JainLabTAMU @bmentamu @NIH

Paper 🚨 : ever wonder how tissue level mechanics like peristalsis contributes to cancer progression? @abbieclev @bmentamu used her peristalsis bioreactor to study how and why! Paper @CMBEjournal @CMBE_BMES : t.ly/MBiTn ; She's also showing off her device!

Peristalsis-Associated Mechanotransduction Drives Malignant Progression of Colorectal Cancer link.springer.com/article/10.100… @theNCI @CPRITTexas @LabRaghavan @bmentamu

Nuclear shapes are geometrically determined by the excess surface area of the nuclear lamina frontiersin.org/articles/10.33… @bmentamu @TAMUEngineering @CPRITTexas @NCIPhySci #AggiesEndCancer

Do cancer cells have memory? Yes, actually they do! In @MBoCjournal, we found that oral squamous cell carcinoma (OSCC) "learns" in the stiff tumor and then "recalls" their memories once in tumor adjacent stroma. molbiolcell.org/doi/10.1091/mb… #mechanobiology #CancerResearch

Recent coverage of an employee of #CPRIT grantee @OncoNano and the life sciences surge in the DFW area. ". . . the reputation of this region as the intellectual capital of the state will continue to grow.” #TexansConquerCancer ow.ly/2E6X50OT3rH

Harnessing αβ T cell receptor mechanobiology to achieve the promise of immuno-oncology | PNAS pnas.org/doi/10.1073/pn… @bmentamu @TAMUEngineering #AggiesEndCancer

June is #CancerImmunotherapyAwarenessMonth. Immunotherapy is a game-changer in the fight against cancer, and at CPRIT, we're proud to support researchers and companies advancing this field. #TexansConquerCancer

#BrainCancer is more common in men than women. The rate of new cases is higher than average for Non-Hispanic Whites of both sexes. Visit our Cancer Stat Facts sheet to learn more: buff.ly/2IlAAe3 #BrainTumorThursday #MensHealthWeek

Meet Blue, a healthy mixed-breed pup who fought two battles with cancer and survived, thanks to her owner Dr. Meriam Saleh’s colleagues at @tamuvetmed! After surgery, rounds of chemotherapy, and love from her Aggie oncology team, Blue is now cancer free: tx.ag/VetMedBlue

We propose that the nucleus is highly compliant to shape changes in motile cells, and that the surfaces of such a compliant nucleus tend to track the motion of the cell boundary. @bmentamu aippub.org/437vSaS

June is #NationalCancerSurvivorMonth. As of January 1, 2020, about 5% of the entire US population are living with a cancer diagnosis. Over a quarter of people 75 and older are living with cancer. Visit SEER*Explorer for more cancer statistics: buff.ly/45BiRY7

Paper published in Soft Matter on biomimetic 3D in vitro models from @LabRaghavan at @bmentamu pubs.rsc.org/en/content/art… Study funded by @NIH

This investment also brings nuanced single cell sequencing technology and clinicogenomics to solve cancer problems.

Meet the leaders of @CPRITTexas Center for Excellence in Cancer Research (TREC) @TAMU Directors Ken Ramos and Robb Chapkin Project Leaders: @LabRaghavan @Irtisha_Singh @ChakrabortySLab @s8shogo Mission: linking gene-environment-lifestyle interactions in cancer #AggiesEndCancer

The #CPRIT Oversight Committee meeting starts at 9am. Be sure to WATCH LIVE as $73 million in grants are awarded to Texas companies and institutions in the fight against cancer! #TexansConquerCancer meeting.cprit.texas.gov

Durable antitumour responses can be triggered by maximizing the cooperative phagocytic potency of macrophages through the disruption of the CD47–SIRPα macrophage checkpoint and by delivering a tumour-opsonizing monoclonal antibody. rdcu.be/daGI9